CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Tobias Skillbäck(Sahlgrenska University Hospital), Henrik Zetterberg(University of Wisconsin–Madison), Maria Eriksdotter(Karolinska University Hospital), Lars Rosengren(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Lena Kilander(Uppsala University), Christoffer Rosén(Uppsala University), Dorota Religa(Karolinska Institutet), Niklas Mattsson(Malmö University), Jonathan M. Schott(UK Dementia Research Institute), Katarina Nägga(Uppsala University), Bengt Winblad(Karolinska Institutet), Jonathan W. Bartlett(Uppsala University), Anders Wimo(Karolinska Institutet), Bahman Farahmand(Stockholm County Council)
Cited by 267
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
An active and socially integrated lifestyle in late life might protect against dementia
|The Lancet Neurology|2004|2.1k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k